Skip to content

Kewaunee Scientific Corporation KEQU Other accrued liabilities

Other accrued liabilities at other companies

Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID

Other financials

Income statement

See full
Revenue$71.4M-7.5%
Gross profit$21.2M-11.6%
Operating income$5.2M-38.6%
Net income$3.4M-30.1%
EPS (diluted)$1.13-30.7%

Balance sheet

See full
Cash & equivalents$10.0M-42.0%
Total debt$25.3M+6.6%
Total equity$74.7M+15.9%
Total assets$178.3M-8.4%

Cash flow

See full
Operating cash flow$5.5M-42.0%
CapEx$928.0K+79.8%
Free cash flow$4.5M-49.0%

Valuation

See full
Market cap$101.96M-32.7%
Enterprise value$117.3M-26.0%
P/E10.6×-2.7×
P/S0.4×-0.3×

Profitability

See full
Gross margin28.5%-0.1pp
Operating margin5.9%-1.5pp
Net margin3.4%-1.3pp
FCF margin5.2%

Returns & leverage

See full
Return on equity13.8%-5.3pp
Debt / equity0.3×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by Kewaunee Scientific Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.

The official record: Kewaunee Scientific Corporation’s 10-K, filed June 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kewaunee Scientific Corporation's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kewaunee Scientific Corporation's other accrued liabilities?
Kewaunee Scientific Corporation (KEQU) reported other accrued liabilities of $3.24M in Q1 2026.
How has Kewaunee Scientific Corporation's other accrued liabilities changed year-over-year?
Kewaunee Scientific Corporation's other accrued liabilities decreased by 3.2% year-over-year, from $3.35M to $3.24M.
What is the long-term trend for Kewaunee Scientific Corporation's other accrued liabilities?
Over 5 years (2021 to 2026), Kewaunee Scientific Corporation's other accrued liabilities has grown at a 19.1% compound annual growth rate (CAGR), from $1.36M to $3.24M.